Standard BioTools Expects To Achieve $45M-$50M In Annualized Operating Expense Savings In Fiscal 2025
Standard BioTools Expects To Achieve $45M-$50M In Annualized Operating Expense Savings In Fiscal 2025
Standard BioTools預計將在2025財年實現4500萬至5000萬美元的年化運營費用節省
Standard BioTools Expects To Achieve $45M-$50M In Annualized Operating Expense Savings In Fiscal 2025
Standard BioTools預計將在2025財年實現4500萬至5000萬美元的年化運營費用節省
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。